Celularity Inc. Files 2024 Proxy Statement

Ticker: CELUW · Form: DEF 14A · Filed: Nov 19, 2024 · CIK: 1752828

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

Related Tickers: CELU

TL;DR

Celularity (CELU) proxy filed for Oct 19 meeting. Vote your shares!

AI Summary

Celularity Inc. filed its definitive proxy statement for its 2024 Annual Meeting of Stockholders, to be held on October 19, 2024. The filing, submitted on November 19, 2024, details the company's governance and proposals to be voted on by shareholders. Celularity Inc. was formerly known as GX Acquisition Corp. until a name change on September 12, 2018.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company matters, impacting the future direction and governance of Celularity Inc.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently introduce new risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this DEF 14A filing?

This DEF 14A filing is a definitive proxy statement filed by Celularity Inc. to provide shareholders with information regarding the 2024 Annual Meeting of Stockholders.

When is the 2024 Annual Meeting of Stockholders scheduled to take place?

The 2024 Annual Meeting of Stockholders is scheduled to be held on October 19, 2024.

What was Celularity Inc. formerly known as?

Celularity Inc. was formerly known as GX Acquisition Corp. until a name change on September 12, 2018.

On what date was this definitive proxy statement filed with the SEC?

This definitive proxy statement was filed with the SEC on November 19, 2024.

What is the SIC code for Celularity Inc.?

The Standard Industrial Classification (SIC) code for Celularity Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 4,817 words · 19 min read · ~16 pages · Grade level 10.2 · Accepted 2024-11-19 16:15:13

Key Financial Figures

Filing Documents

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 24 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 33 HOUSEHOLDING 39 STOCKHOLDER PROPOSALS 39 OTHER MATTERS 40 3 CELULARITY INC. 170 Park Avenue Florham Park, New Jersey 07932. PROXY FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 19, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING GENERAL INFORMATION How do I attend and participate in the Annual Meeting? The Annual Meeting will be held on December 19, 2024 at 1:00 p.m. Eastern Time at Celularity’s headquarters located at 170 Park Avenue, Florham Park, New Jersey. Information on how to vote in person at the Annual Meeting is discussed below. When are this proxy statement and the accompanying materials scheduled to be sent to stockholders? The proxy materials, including this proxy statement, a proxy card for shares held in street name ( i.e., held for your account by a broker of other nominee), or voting instruction card and the Annual Report on Form 10-K for the year ended December 31, 2023, or the 2023 Annual Report, are first being mailed to stockholders on or about November 19, 2024. These materials are also available for viewing, printing and downloading on the Internet at http://www.viewproxy.com/celularity/2024 Who is soliciting my vote? Our board of directors is soliciting your vote for the Annual Meeting, including at any adjournments or postponements of the meeting. When is the record date for the Annual Meeting? The record date for determination of stockholders entitled to vote at the Annual Meeting is the close of business on November 8, 2024. How many votes can be cast by all stockholders? There were 22,005,358 shares of our Class A common stock, par value $0.0001 per share, outstanding on November 8, 2024, all of which are entitled to vote with respect to all matters to be acted upon at the Annual Meeting. Each stockholder of record is entitled to one vote for each share o

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing